Motilal Oswal BSE Healthcare ETF
Motilal Oswal Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | -3.48% | -0.93% | 230 of 235 |
| 1M | -3.11% | -4.79% | 35 of 235 |
| 3M | -1.27% | -4.32% | 43 of 233 |
| 6M | +19.53% | +4.76% | 14 of 224 |
| YTD | +13.18% | -5.00% | 6 of 235 |
| 1Y | +13.63% | +0.75% | 15 of 192 |
| 2Y | +6.74% | +1.28% | 18 of 151 |
| 3Y | +21.21% | +10.10% | 7 of 123 |
| INCEPTION | +20.19% | — | — |
Ranked among: Exchange Traded Funds (ETFs) - Other ETF.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +5.68% | +26.54% | -13.52% | 71% | 29% |
| 6M | +11.48% | +33.62% | -11.41% | 72% | 31% |
| 1Y | +25.69% | +64.22% | -3.90% | 94% | 44% |
| 2Y | +25.50% | +41.43% | +6.52% | 100% | 48% |
| 3Y | +24.30% | +28.44% | +20.87% | 100% | 49% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Aug 2026
Asset Allocation
- Equity99.90%
- Debt0.00%
- Cash0.10%
- Other0.00%
Market Cap Split
- Large Cap34.91%
- Mid Cap38.82%
- Small Cap26.17%
- Others0.10%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 40.26 | — |
| P/B | 5.68 | — |
| Price / Sales | 5.85 | — |
| Price / Cash Flow | 30.73 | — |
| Dividend Yield (%) | 0.55 | — |
Holdings · Aug 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Sun Pharmaceutical | Pharmaceuticals & Biotechnology | 12.92% | -0.40% |
| Divis Laboratories | Pharmaceuticals & Biotechnology | 7.21% | +0.84% |
| Apollo Hospitals | Equity | 5.53% | -0.14% |
| Cipla | Pharmaceuticals & Biotechnology | 4.90% | -0.27% |
| Max Healthcare Institute | Equity | 4.61% | -0.43% |
| Laurus Labs | Pharmaceuticals & Biotechnology | 4.47% | +0.15% |
| Torrent Pharmaceuticals | Pharmaceuticals & Biotechnology | 4.35% | -0.17% |
| Dr Reddys Laboratories | Pharmaceuticals & Biotechnology | 4.34% | +0.00% |
| Lupin | Pharmaceuticals & Biotechnology | 3.23% | -0.40% |
| Fortis Healthcare | Equity | 2.89% | -0.16% |
| Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.88% | +0.15% |
| Glenmark Pharmaceuticals | Pharmaceuticals & Biotechnology | 2.28% | +0.21% |
| Alkem Laboratories | Pharmaceuticals & Biotechnology | 1.92% | -0.17% |
| Zydus Life Science | Pharmaceuticals & Biotechnology | 1.79% | +0.03% |
| Biocon | Pharmaceuticals & Biotechnology | 1.77% | -0.11% |
View all 126 holdings
| IPCA Laboratories | Pharmaceuticals & Biotechnology | 1.69% | +0.18% |
| Mankind Pharma | Pharmaceuticals & Biotechnology | 1.64% | -0.07% |
| Gland Pharma | Pharmaceuticals & Biotechnology | 1.40% | +0.17% |
| Aster DM Quality Care | Equity | 1.22% | -0.13% |
| Sai Life Sciences | Pharmaceuticals & Biotechnology | 1.21% | +0.10% |
| Neuland Laboratories | Pharmaceuticals & Biotechnology | 1.21% | +0.20% |
| Krishna Institute of Medical Sciences | Equity | 1.14% | -0.10% |
| Acutaas Chemicals | Pharmaceuticals & Biotechnology | 1.00% | +0.01% |
| Wockhardt | Pharmaceuticals & Biotechnology | 0.95% | -0.06% |
| Ajanta Pharma | Pharmaceuticals & Biotechnology | 0.94% | +0.03% |
| Dr. Lal Path Labs | Equity | 0.92% | +0.01% |
| Piramal Pharma | Pharmaceuticals & Biotechnology | 0.82% | +0.06% |
| Narayana Hrudayalaya | Equity | 0.81% | -0.06% |
| Abbott | Pharmaceuticals & Biotechnology | 0.81% | -0.07% |
| Global Health | Equity | 0.78% | +0.03% |
| Anthem Biosciences | Pharmaceuticals & Biotechnology | 0.77% | +0.07% |
| GlaxoSmithKline Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.76% | +0.09% |
| Granules | Pharmaceuticals & Biotechnology | 0.73% | +0.00% |
| Onesource Specialty Pharma | Pharmaceuticals & Biotechnology | 0.72% | -0.06% |
| Shilpa Medicare | Pharmaceuticals & Biotechnology | 0.68% | +0.23% |
| Eris Lifesciences | Pharmaceuticals & Biotechnology | 0.48% | -0.03% |
| Natco Pharma | Pharmaceuticals & Biotechnology | 0.47% | -0.05% |
| Syngene International | Equity | 0.46% | +0.01% |
| Vijaya Diagnostic Centre | Equity | 0.45% | +0.05% |
| Cohance Lifesciences | Pharmaceuticals & Biotechnology | 0.45% | +0.03% |
| Rainbow Childrens Medicare | Equity | 0.44% | -0.04% |
| Pfizer | Pharmaceuticals & Biotechnology | 0.43% | -0.02% |
| Jubilant Pharmova | Pharmaceuticals & Biotechnology | 0.43% | -0.03% |
| Marksans Pharma | Pharmaceuticals & Biotechnology | 0.42% | +0.08% |
| Strides Pharma Science | Pharmaceuticals & Biotechnology | 0.42% | +0.00% |
| Poly Medicure | Equity | 0.40% | +0.00% |
| Indegene | Equity | 0.39% | +0.06% |
| Emcure Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.39% | -0.02% |
| Metropolis Healthcare | Equity | 0.38% | +0.00% |
| Rubicon Research | Pharmaceuticals & Biotechnology | 0.35% | +0.06% |
| Jupiter Life Line Hospital | Equity | 0.34% | -0.04% |
| Caplin Point Laboratories | Pharmaceuticals & Biotechnology | 0.30% | -0.01% |
| Concord Biotech | Pharmaceuticals & Biotechnology | 0.30% | +0.01% |
| Alembic Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.28% | +0.01% |
| Procter & Gamble Health | Pharmaceuticals & Biotechnology | 0.28% | -0.05% |
| Aarti Pharma Labs | Pharmaceuticals & Biotechnology | 0.27% | +0.06% |
| AstraZeneca Pharma | Pharmaceuticals & Biotechnology | 0.27% | -0.04% |
| Alivus Life Sciences | Pharmaceuticals & Biotechnology | 0.26% | +0.04% |
| Yatharth Hospital | Equity | 0.26% | +0.04% |
| Bliss GVS Pharma | Pharmaceuticals & Biotechnology | 0.25% | +0.06% |
| Viyash Scientific | Pharmaceuticals & Biotechnology | 0.25% | +0.01% |
| Dr. Agarwal's Health Care | Equity | 0.24% | +0.01% |
| Healthcare Global Enterprises | Equity | 0.24% | +0.02% |
| Thyrocare Technologies | Equity | 0.23% | +0.01% |
| Morepen Laboratories | Pharmaceuticals & Biotechnology | 0.23% | +0.11% |
| Senores Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.22% | +0.02% |
| Suven Life Sciences | Equity | 0.18% | +0.04% |
| Sanofi | Pharmaceuticals & Biotechnology | 0.17% | -0.01% |
| Kovai Medical Center Hospital | Equity | 0.17% | +0.00% |
| Sanofi Consumer Healthcare | Pharmaceuticals & Biotechnology | 0.17% | -0.02% |
| Akums Drugs & Pharma | Pharmaceuticals & Biotechnology | 0.16% | +0.02% |
| IOL Chemicals & Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.14% | +0.04% |
| Supriya Lifescience | Pharmaceuticals & Biotechnology | 0.13% | -0.01% |
| Blue Jet Healthcare | Pharmaceuticals & Biotechnology | 0.12% | -0.01% |
| Sun Pharma Advanced Research Co | Pharmaceuticals & Biotechnology | 0.12% | +0.00% |
| Innova Captab | Pharmaceuticals & Biotechnology | 0.11% | +0.01% |
| FDC | Pharmaceuticals & Biotechnology | 0.10% | -0.02% |
| Park Medi World | Equity | 0.10% | +0.00% |
| Indraprastha Medical Corporation | Equity | 0.10% | +0.00% |
| Artemis Medicare Services | Equity | 0.10% | +0.01% |
| Net Receivables / (Payables) | Net Current Assets | 0.10% | — |
| Nephrocare Health Services | Equity | 0.09% | +0.00% |
| Kwality Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.09% | +0.02% |
| Orchid Pharma | Pharmaceuticals & Biotechnology | 0.09% | +0.00% |
| Solara Active Pharma Sciences | Pharmaceuticals & Biotechnology | 0.09% | +0.02% |
| Aarti Drugs | Pharmaceuticals & Biotechnology | 0.09% | +0.00% |
| Advanced Enzyme Tech | Pharmaceuticals & Biotechnology | 0.08% | -0.01% |
| Gujarat Themis Biosyn | Pharmaceuticals & Biotechnology | 0.08% | +0.01% |
| Corona Remedies | Pharmaceuticals & Biotechnology | 0.08% | +0.00% |
| Dishman Carbogen Amcis | Pharmaceuticals & Biotechnology | 0.07% | +0.00% |
| Unichem Laboratories | Pharmaceuticals & Biotechnology | 0.07% | +0.00% |
| RPG Life Sciences | Pharmaceuticals & Biotechnology | 0.07% | +0.00% |
| Gufic BioSciences | Pharmaceuticals & Biotechnology | 0.07% | +0.00% |
| Novartis | Pharmaceuticals & Biotechnology | 0.07% | +0.00% |
| SMS Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.07% | +0.00% |
| Krsnaa Diagnostics | Equity | 0.06% | +0.00% |
| Vimta Labs | Equity | 0.06% | +0.00% |
| Indoco Remedies | Pharmaceuticals & Biotechnology | 0.05% | +0.00% |
| Syncom Formulations | Pharmaceuticals & Biotechnology | 0.05% | +0.01% |
| Fischer Medical Ventures | Equity | 0.05% | -0.01% |
| Hester Biosciences | Pharmaceuticals & Biotechnology | 0.05% | -0.01% |
| Sigachi Industries | Pharmaceuticals & Biotechnology | 0.05% | +0.01% |
| Windlas Biotech | Pharmaceuticals & Biotechnology | 0.05% | +0.01% |
| Hikal | Pharmaceuticals & Biotechnology | 0.05% | +0.00% |
| 3B BlackBio DX | Equity | 0.04% | +0.00% |
| Suraksha Diagnostic | Equity | 0.04% | +0.01% |
| Dr. Agrawals Eye Hospital | Equity | 0.04% | +0.00% |
| Panacea Biotec | Pharmaceuticals & Biotechnology | 0.04% | +0.00% |
| Kopran | Pharmaceuticals & Biotechnology | 0.04% | +0.01% |
| Lincoln Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.04% | +0.01% |
| KMC Speciality Hospitals | Equity | 0.03% | +0.00% |
| Tarsons Products | Equity | 0.03% | +0.00% |
| Wanbury | Pharmaceuticals & Biotechnology | 0.03% | -0.01% |
| Fermenta Biotech | Pharmaceuticals & Biotechnology | 0.03% | +0.00% |
| Jagsonpal Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.03% | +0.00% |
| GPT Healthcare | Equity | 0.03% | +0.00% |
| Shalby | Equity | 0.03% | +0.00% |
| Bajaj HealthCare | Pharmaceuticals & Biotechnology | 0.02% | -0.01% |
| Laxmi Dental | Equity | 0.02% | +0.00% |
| Gujarat Kidney and Super Speciality | Equity | 0.02% | +0.00% |
| Themis Medicare | Pharmaceuticals & Biotechnology | 0.02% | +0.00% |
| Anuh Pharma | Pharmaceuticals & Biotechnology | 0.01% | +0.00% |
| Health X Platform | Equity | 0.01% | +0.00% |
| Shree Ganesh Remedies | Pharmaceuticals & Biotechnology | 0.01% | +0.00% |
| Fabtech Technologies | Equity | 0.01% | +0.00% |
| Nectar Lifesciences | Pharmaceuticals & Biotechnology | 0.01% | +0.00% |
Sector Allocation · Aug 2026
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 17.07 | 14.22 | High Volatility |
| 3Y | 16.51 | 16.08 | High Volatility |
What is this?
Risk as measured by standard deviation is a statistical measure that quantifies the amount of variation or dispersion in a set of data points relative to its mean (average).
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.73 | 1.00 | Poor Risk Adjusted Returns |
| 3Y | 0.87 | 0.94 | Poor Risk Adjusted Returns |
What is this?
Higher the value means that fund has been able to give better returns for the amount of risk taken. It helps investors understand the return of an investment compared to its risk, showing whether the returns are due to intelligent investing or simply taking on excess risk. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the standard deviation of returns.
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 1.19 | 1.82 | Poor Risk Adjusted Returns |
| 3Y | 1.47 | 1.63 | Poor Risk Adjusted Returns |
What is this?
The Sortino Ratio is a financial metric used to measure the risk-adjusted return of an investment. It's a modification of the Sharpe Ratio but with a key difference; it only considers downside risk (the risk of negative returns), rather than total volatility. This means it focuses on how well an investment performs relative to the volatility that leads to losses, ignoring the volatility that results in gains. The idea is that investors are primarily concerned with minimizing losses, and positive volatility is generally seen as a good thing.
Beta
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 1.01 | 0.94 | Poor Risk Adjusted Returns |
| 3Y | 1.00 | 0.95 | Poor Risk Adjusted Returns |
What is this?
This value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market.
Tracking Difference
Versus BSE Health Care - TRI, as of Aug 2026.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
| Tata Silver Exchange Traded Fund | +54.78% | — | — | +50.51% |
| ICICI PRUDENTIAL SILVER ETF | +52.40% | +47.61% | — | +29.58% |
| Kotak Silver ETF | +52.29% | +47.52% | — | +35.10% |
|
SBI Silver ETF
Regular Plan · Growth
|
+52.16% | — | — | +47.07% |
| Edelweiss Silver ETF | +52.00% | — | — | +45.57% |
|
Nippon India Silver ETF
Direct Plan
|
+51.90% | +47.19% | — | +30.64% |
| Motilal Oswal Silver ETF | +51.57% | — | — | +76.32% |
|
HDFC Silver ETF
Growth Option
|
+51.56% | +47.81% | — | +41.06% |
|
Zerodha Silver ETF
Direct Plan
|
+50.95% | — | — | +67.53% |
| Motilal Oswal Nasdaq Q50 ETF | +40.73% | +32.02% | — | +13.87% |
More From Motilal Oswal Asset Management Company Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
| Motilal Oswal Silver ETF | +51.57% | — | — | +76.32% |
|
Motilal Oswal Nasdaq 100 Fund of Fund
Direct plan · Growth
|
+41.16% | +38.90% | +24.55% | +27.08% |
| Motilal Oswal Nasdaq Q50 ETF | +40.73% | +32.02% | — | +13.87% |
| Motilal Oswal Nasdaq 100 ETF | +33.73% | +33.90% | +21.91% | +23.84% |
|
Motilal Oswal Gold and Silver Passive Fund of Funds
Direct Plan · Growth
|
+31.75% | +38.49% | — | +32.35% |
|
Motilal Oswal Active Momentum Fund
Direct Plan · Reinvestment/Payout
|
+26.04% | — | — | +27.23% |
| Motilal Oswal Gold ETF | +24.99% | — | — | +39.39% |
|
Motilal Oswal Focused Fund
Direct Plan · Growth
|
+24.86% | +14.61% | +10.34% | +14.65% |
|
Motilal Oswal S&P 500 Index Fund
Direct Plan · GROWTH
|
+24.35% | +27.72% | +18.70% | +21.32% |
|
Motilal Oswal Developed Market Ex US ETFs Overseas Equity Passive FOF
Direct Plan · Growth
|
+23.27% | +23.10% | — | +23.05% |
About This Scheme
Investment Objective
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the S&P BSE Healthcare Total Return Index, subject to tracking error. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch